Leveraging the Immune Response from LIFE Biomaterial and Photon-Flash in Pre-Clinical Pancreatic Cancer Treatment

Pre-clinical animal studies evaluating the ‘flash effect’ caused by ultra-high dose rate (≥40 Gy/s) favorably spares normal tissue from radiation-caused toxicity while maintaining anti-tumor effects like conventional (CONV) radiation. The goal of this study is to leverage an immune response resultin...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:Pharmaceutics
المؤلفون الرئيسيون: Michele Moreau, Katelyn Kelly, Serena Mao, Debarghya China, Girmachew Wasihun, Aditya Pandya, MohammadAli Tajik-Mansoury, Daniel Sforza, Devin Miles, Amol K. Narang, Mohammad Rezaee, Wilfred Ngwa, Kai Ding
التنسيق: مقال
اللغة:الإنجليزية
منشور في: MDPI AG 2025-09-01
الموضوعات:
ultra-high dose rate (≥40 Gy/s) Flash
LIFE Biomaterial
radiotherapy
immune response
immunohistochemistry
الوصول للمادة أونلاين:https://www.mdpi.com/1999-4923/17/10/1273

الانترنت

https://www.mdpi.com/1999-4923/17/10/1273

مواد مشابهة